The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAE Systems Regulatory News (BA.)

Share Price Information for BAE Systems (BA.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,369.00
Bid: 1,369.00
Ask: 1,369.50
Change: 29.00 (2.16%)
Spread: 0.50 (0.037%)
Open: 1,347.00
High: 1,376.50
Low: 1,345.00
Prev. Close: 1,340.00
BA. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Jul 2022 09:13

RNS Number : 3533R
BAE SYSTEMS PLC
05 July 2022
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

BAE Systems PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

The Capital Group Companies, Inc.

City and country of registered office (if applicable)

Los Angeles, USA

4. Full name of shareholder(s)  (if different from 3.)

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

01/07/2022

6. Date on which issuer notified (DD/MM/YYYY):

05/07/2022

7. Total positions of person(s) subject to the notification obligation:

% of voting rights attached to shares

(total of 8.A)

% of voting rights through financial instruments

(total of 8.B.1 + 8.B.2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

12.01%

0.00%

12.01%

3,157,073,725

Position of previous notification (if applicable)

11.35%

0.00%

11.35%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB0002634946 Common Stock

344,904,981

10.92%

US05523R1077 Depository Receipt

34,354,832

1.09%

SUBTOTAL 8.A

379,259,813

12.01%

B 1: Financial Instruments DTR5.3.1R (1) (a)

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

N/A

SUBTOTAL 8.B.1

B 2: Financial Instruments with similar economic effect DTR5.3.1R (1) (b)

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

N/A

SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Capital Research and Management Company

11.94%

11.94%

Capital International, Inc.

Capital International Sarl

Total

12.01%

12.01%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information:

 

The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of six investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl, Capital International K.K., Capital Group Private Client Services Inc, and Capital Group Investment Management Private Limited. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.

Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.

 

 

Place of completion

Los Angeles

Date of completion

05/07/2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLGIGDRDBGDGDU
Date   Source Headline
23rd Apr 20245:43 pmRNSTransaction in Own Shares
22nd Apr 20245:25 pmRNSTransaction in Own Shares
19th Apr 20245:23 pmRNSTransaction in Own Shares
18th Apr 20246:22 pmRNSTransaction in Own Shares
18th Apr 20244:48 pmRNSDirector/PDMR Shareholding
17th Apr 20245:38 pmRNSTransaction in Own Shares
17th Apr 20241:39 pmRNSDirector/PDMR Shareholding
16th Apr 20246:01 pmRNSTransaction in Own Shares
15th Apr 20245:26 pmRNSTransaction in Own Shares
12th Apr 20245:16 pmRNSTransaction in Own Shares
11th Apr 20246:30 pmRNSTransaction in Own Shares
11th Apr 202411:15 amRNSDoc re: AGM documents
10th Apr 20246:05 pmRNSTransaction in Own Shares
9th Apr 20246:23 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
5th Apr 20241:04 pmRNSDirector/PDMR Shareholding
4th Apr 20245:23 pmRNSTransaction in Own Shares
3rd Apr 20245:09 pmRNSTransaction in Own Shares
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:41 pmRNSTransaction in Own Shares
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:38 pmRNSDirector/PDMR Shareholding
28th Mar 202411:25 amRNSDirector Declaration
28th Mar 202410:50 amRNSTotal Voting Rights
27th Mar 20245:25 pmRNSTransaction in Own Shares
26th Mar 20245:04 pmRNSTransaction in Own Shares
25th Mar 20245:14 pmRNSTransaction in Own Shares
22nd Mar 20245:33 pmRNSTransaction in Own Shares
21st Mar 20246:22 pmRNSTransaction in Own Shares
21st Mar 20242:03 pmRNSDirector/PDMR Shareholding
20th Mar 20245:52 pmRNSTransaction in Own Shares
20th Mar 202412:22 pmRNSDirector/PDMR Shareholding
20th Mar 20249:15 amRNSNotes Issuance
19th Mar 20245:43 pmRNSTransaction in Own Shares
18th Mar 20245:46 pmRNSTransaction in Own Shares
15th Mar 20245:50 pmRNSTransaction in Own Shares
15th Mar 202412:31 pmRNSDirector/PDMR Shareholding
14th Mar 20246:11 pmRNSTransaction in Own Shares
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:06 pmRNSTransaction in Own Shares
11th Mar 20246:26 pmRNSTransaction in Own Shares
11th Mar 202412:30 pmRNSDirector/PDMR Shareholding
8th Mar 20245:26 pmRNSTransaction in Own Shares
7th Mar 20246:21 pmRNSTransaction in Own Shares
7th Mar 20249:00 amRNSPublication of 2023 Annual Report
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20246:06 pmRNSTransaction in Own Shares
5th Mar 20242:32 pmRNSNotice of Results
4th Mar 20244:57 pmRNSTransaction in Own Shares
1st Mar 20245:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.